AtriCure Closes Enrollment for Largest Cardiac Clinical Study

AtriCure recently closed its LeAAPS clinical trial, the largest randomized cardiac surgery clinical trial to date, with 6,500 patients participating to help prevent strokes and/or embolisms – setting a benchmark in the industry. The City of Mason has partnered with AtriCure for more than a decade, supporting its advancement of cardiac care and innovation in the Mason Biohub.